Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Human Mesenchymal Stem Cell Conditioned Medium for Chronic Inflammation
jRCT1051240290Recruiting
- Sponsor
- Seihoku Clinic
- Start
- Mar 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in chronic inflammation, sponsored by Seihoku Clinic. Primary endpoints: Change in C-reactive protein (CRP), Change in growth differentiation factor 15 (GDF15) and 1 more. Started Mar 2025; status: recruiting.
02
Conditions
chronic inflammation
Beyond the preview
Go deeper on jRCT1051240290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240290.